Cite
HARVARD Citation
Jiang, M. et al. (2021). FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III. Journal for immunotherapy of cancer. 9 (5), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jiang, M. et al. (2021). FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III. Journal for immunotherapy of cancer. 9 (5), p. . [Online].